Merck second quarter profit tops estimates on strong consumer sales

A view of the Merck & Co. campus in Linden, New Jersey(Reuters) – Merck & Co Inc reported better-than-expected quarterly results on Tuesday, with sales of consumer products and medicines for arthritis and HIV helping to offset the impact of generic competition on other drug sales. Merck, the No. 2 U.S. drugmaker, earned $ 2.03 billion, or 68 cents per share, in the second quarter. Analysts, on average, expected 81 cents, according to Thomson Reuters I/B/E/S. Global revenue slipped 1 percent to $ 10.93 billion, but exceeded expectations of $ 10.6 billion. On May 6, it agreed to sell its consumer care business to Germany’s Bayer AG for $ 14.2 billion, and expects to close the deal in the second half of the year.

Sexual Health News Headlines – Yahoo! News